{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:48:16Z","timestamp":1777481296870,"version":"3.51.4"},"reference-count":57,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Over the past decade, there has been increased utilization of medical cannabis (MC) in the United States. Few studies have described sociodemographic and clinical factors associated with MC use after certification and more specifically, factors associated with use of MC products with different cannabinoid profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We conducted a longitudinal cohort study of adults (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      =225) with chronic or severe pain on opioids who were newly certified for MC in New York State and enrolled in the study between November 2018 and January 2022. We collected data over participants' first 3 months in the study, from web-based assessment of MC use every 2 weeks (unit of analysis). We used generalized estimating equation models to examine associations of sociodemographic and clinical factors with (1) MC use (vs. no MC use) and (2) use of MC products with different cannabinoid profiles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>On average, 29% of the participants used predominantly high delta-9-tetrahydrocannabinol (THC) MC products within the first 3 months of follow-up, 30% used other MC products, and 41% did not use MC products. Non-Hispanic White race, pain at multiple sites, and past 30-day sedative use were associated with a higher likelihood of MC use (vs. no MC use). Current tobacco use, unregulated cannabis use, and enrollment in the study during the COVID-19 pandemic were associated with a lower likelihood of MC use (vs. no MC use). Among participants reporting MC use, female gender and older age were associated with a lower likelihood of using predominantly high-THC MC products (vs. other MC products).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>White individuals were more likely to use MC after certification, which may be owing to access and cost issues. The findings that sedative use was associated with greater MC use, but tobacco and unregulated cannabis were associated with less MC use, may imply synergism and substitution that warrant further research. From the policy perspective, additional measures are needed to ensure equitable availability of and access to MC. Health practitioners should check patients' history and current use of sedative, tobacco, and unregulated cannabis before providing an MC recommendation and counsel patients on safe cannabis use.<\/jats:p>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">clinicaltrials.gov<\/jats:ext-link>\n                      (NCT03268551)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2022.0248","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T10:47:53Z","timestamp":1679654873000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3233-3905","authenticated-orcid":false,"given":"Chenshu","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Montefiore Health System, Bronx, New York, USA."},{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika E.","family":"Slawek","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Montefiore Health System, Bronx, New York, USA."},{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-3048","authenticated-orcid":false,"given":"Jonathan","family":"Ross","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Montefiore Health System, Bronx, New York, USA."},{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Zolotov","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Montefiore Health System, Bronx, New York, USA."},{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Castillo","sequence":"additional","affiliation":[{"name":"Division on Substance Use Disorders, NY State Psychiatric Institute, New York, New York, USA."},{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[{"name":"Division on Substance Use Disorders, NY State Psychiatric Institute, New York, New York, USA."},{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Sohler","sequence":"additional","affiliation":[{"name":"Department of Community Health and Social Medicine, City University of New York, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Psychology, Fordham University, Bronx, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna L.","family":"Starrels","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Montefiore Health System, Bronx, New York, USA."},{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Montefiore Health System, Bronx, New York, USA."},{"name":"Department of Medicine, Einstein College of Medicine, New York, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.019"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05266"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0064"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.06.005"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-020-00038-w"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.03.009"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0775-9"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2014.02.005"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2016.0007"},{"key":"e_1_3_4_12_2","unstructured":"National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: an Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press (U.S.): Washington DC USA 2017. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK423845\/ (accessed July7 2022)."},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-06047-8"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.03.002"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/1533210107301834"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2019.04.002"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18ac12537"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.2174\/092986710790980050"},{"key":"e_1_3_4_19_2","unstructured":"Slawek D Arnsten JH Whitley SD et al. Therapeutic Use of Medical Cannabis in New York State [Internet]. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK577724\/ (accessed July7 2022)."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13076-1"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0020"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0278-6"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103053"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043400"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnab257"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103202"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.0528"},{"key":"e_1_3_4_28_2","unstructured":"New York State Department of Health. New York State Medical Marijuana Program. Available online: https:\/\/cannabis.ny.gov\/registered-organizations (accessed December15 2022)."},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-0981-1"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.7.4.524"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.5.601"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-110"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2004.04.005"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0298"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"e_1_3_4_38_2","unstructured":"U.S. Department of Commerce. National Cancer Institute and Food and Drug Administration co-sponsored Tobacco Use Supplement to the Current Population Survey. 2016. Available online: https:\/\/cancercontrol.cancer.gov\/brp\/tcrb\/tus-cps (accessed March9 2023)."},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb02093.x"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01513-7"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.13"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.85.4.858"},{"key":"e_1_3_4_43_2","unstructured":"SAS Institute. Base SAS 9.4 procedures guide: statistical procedures. Cary North Carolina: SAS Institute; 2017."},{"key":"e_1_3_4_44_2","first-page":"257","article-title":"Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State","volume":"5","author":"Carter GT","year":"2009","unstructured":"Carter GT, , Sullivan MD, , ZumBrunnen C, et al. Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. J Opioid Manag. 2009; 5:257\u2013286.","journal-title":"J Opioid Manag"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.18900"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265161.2019.1567193"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0541-4"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncom.2018.00018"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2021.1903479"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.08.001"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.017"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.12.008"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03843.x"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2020.1811455"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108770"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0120"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-54564-6_22"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8020290"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2022.0248","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2022.0248","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2022.0248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:12:07Z","timestamp":1777385527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2022.0248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6,1]]}},"alternative-id":["10.1089\/can.2022.0248"],"URL":"https:\/\/doi.org\/10.1089\/can.2022.0248","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}